Dariusz Bielicki

Dariusz Bielicki

Auto-generated profile, based on publicly available information

Dariusz Bielicki

Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VSVioletta Sulżyc-Bielicka
Violetta Sulżyc-Bielicka
LKLidia Kołodziejczyk
Lidia Kołodziejczyk
SJSylwia Jaczewska
Sylwia Jaczewska
DBDariusz Bielicki
Dariusz Bielicki
KSKrzysztof Safranow
Krzysztof Safranow
WRWojciech Rogowski
Wojciech Rogowski
Transient or constant impaired immunity is often associated with neoplastic disease or oncological treatment. Among the most common pathogens found in patients with HIV or patients undergoing chemotherapy are protozoans of the Cryptosporidium genus, which cause diarrhea in humans and animals. The present study determined the frequency of Cryptosporidium spp. infections in patients with colorectal cancer (N = 108; 42 women; 66 men; median age, 65 years), before beginning oncological treatment, compared to a control group (N = 125; 56 women, 69 men; median age, 63 years) without colorectal cancer or a history of oncological disease. We also assessed whether Cryptosporidium spp. infections were associated with age, gender, cancer stage (based on Astler-Coller or TNM classification), histological grade, or cancer location. Patients were treated at the Pomeranian Medical University, in 2009–2014. The presence of Cryptosporidium spp. antigen was determined in stool samples, analyzed with a commercial immunoenzymatic test. Cryptosporidium spp. infections occurred significantly more often (p = 0.015) in patients (13%) compared to controls (4%). The patient group showed no significant relationship between Cryptosporidium spp. infection and sex, age, tumor location, cancer grade, or stage. A multivariate logistic regression analysis adjusted for age and sex that included all subjects (patient + control groups, n = 233) showed that the odds of a Cryptosporidium spp. infection were more than three-fold higher in patients than in controls, and more than six-fold higher among men than among women. Conclusions: 1) Cryptosporidium spp. infections occurred significantly more frequently in patients with colorectal cancer (before oncological treatment) compared to controls, independent of age and sex. 2) Cryptosporidium spp. infections were not associated with the colorectal cancer stage, grade, or location or with patient age. 3) Male gender was significantly related to the frequency of Cryptosporidium spp. infections, independent of age and the presence of colorectal cancer.

12 June 2010 in International Journal of Colorectal Disease
Verified
Journal Article
Open access
PDF file
Michał P. WasilewiczMichał P. Wasilewicz
Michał P. Wasilewicz
BKBlanka Kołodziej
Blanka Kołodziej
TBTeresa Bojułko
Teresa Bojułko
MKMariusz Kaczmarczyk
Mariusz Kaczmarczyk
VSVioletta Sulżyc-Bielicka
Violetta Sulżyc-Bielicka
KCKatarzyna Ciepiela
Katarzyna Ciepiela
Purpose We aimed to study the intracellular expression of 5-lipoxygenase (5-LOX), the primary competitor with cyclooxygenase-2 in arachidonic acid metabolism, as inflammatory enzymes may be involved in blocking apoptosis and promoting cancer growth by changing arachidonic acid metabolism within cells. Our purpose was to investigate the possible connection between 5-LOX expression and colon carcinogenesis by characterizing 5-LOX expression in histologically different colonic adenomas, determining the relationship between high expression of 5-LOX and various conventional clinicopathological features of adenomas, and finally characterizing the histological localization of cells with 5-LOX overexpression. Methods A total of 111 patients were examined and 120 histologically different colonic adenomas analyzed (including four cases of intramucosal adenocarcinoma in a polyp). Immunohistochemical staining with polyclonal anti-5-LOX antibodies was performed. Results There was a significant correlation between high 5-LOX expression and patient age, increased polyp size, high grade of intraepithelial neoplasia, villous and tubulovillous adenoma, and histological epithelial localization. Conclusions We observed a strong positive correlation between 5-LOX overexpression and the appearance of typical high-risk factors for malignant transformation in adenomatous polyps. The results support the role of 5-LOX in early stages of colon carcinogenesis.

1 June 2007 in Journal of Parasitology
Verified
Journal Article
Closed access
VSV. Sulżyc-Bielicka
V. Sulżyc-Bielicka
WKW. Kuźna-Grygiel
W. Kuźna-Grygiel
LKL. Kołodziejczyk
L. Kołodziejczyk
DBD. Bielicki
D. Bielicki
JKJ. Kładny
J. Kładny
BTB. Telatyńska-Śmieszek
B. Telatyńska-Śmieszek
Parasitological examination of feces was carried out for 55 patients with diagnosed colorectal cancer before chemotherapy. Except for Cryptosporidium sp., no other intestinal parasites were found in the specimens; moreover, only the patients with watery diarrhea were Cryptosporidium sp.-positive by enzyme immunoassay. Prevalence of infection in the group of patients with diarrhea (23 persons) was 43.5%, whereas it was 18% for the entire group of patients under study. Coproantigens of this parasite were detected primarily in the patients with tumors located on the left side (in the sigmoid and descending colon).

1 January 2012 in Polish Journal of Surgery
Verified
Journal Article
Open access
PDF file
VSVioletta Sulżyc-Bielicka
Violetta Sulżyc-Bielicka
LKLidia Kołodziejczyk
Lidia Kołodziejczyk
SJSylwia Jaczewska
Sylwia Jaczewska
DBDariusz Bielicki
Dariusz Bielicki
JKJózef Kładny
Józef Kładny
KSKrzysztof Safranow
Krzysztof Safranow
Parasitic protozoans of the Cryptosporidium genus are intracellular intestinal parasites of mammals, causing cryptosporidiosis. Clinically, cryptosporidiosis manifests as chronic diarrhoea. Individuals with immune disorders, including those with neoplasms, are at risk of symptomatic invasion. Was the evaluation of Cryptosporidium sp. prevalence in patients with diagnosed colorectal cancer. The studied group encompassed 87 patients with diagnosed colorectal cancer, undergoing surgery at the Department of General and Oncological Surgery, Pomeranian Medical University, in the years 2009-2010. Immunoenzymatic tests for Cryptosporidium sp. on faeces samples were performed with the use of commercial test kit, ProSpecT(®)Cryptosporidium Microplate Assay (Remel Inc). The presence of Cryptosporidium sp. was found in 12.6% of studied patients with colorectal cancer. The performed statistical analysis did not reveal any correlation between Cryptosporidium sp. infection and gender, age, neoplasm advancement stage as per Astler-Coller scale, neoplasm differentiation grade, or neoplastic tumour localisation in relation to the splenic flexure. There was found high prevalence of Cryptosporidium sp. in patients with colorectal cancer. It was comparable to the prevalence reported for patients with immune deficiency.

1 June 2014 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
ABAndrzej Białek
Andrzej Białek
JPJan Pertkiewicz
Jan Pertkiewicz
KKKatarzyna Karpińska
Katarzyna Karpińska
Wojciech M. MarliczWojciech M. Marlicz
Wojciech M. Marlicz
DBDariusz Bielicki
Dariusz Bielicki
TSTeresa Starzyńska
Teresa Starzyńska
Endoscopic submucosal dissection (ESD) has a high curative resection rate for gastrointestinal mucosal lesions, but is not used widely in Europe because of a high complication rate and a long learning curve. This study analyzed the ESD learning curve at a single European treatment center. ESD and hybrid-ESD (hESD) procedures were used to treat large colonic lesions that could not be resected in one piece by other endoscopic methods. Procedure duration and speed, and en-bloc, complete (R0) resection, and complication rates were analyzed. Fifty-three patients underwent ESD (37 pure ESD, 16 hESD), most with rectal lesions (n=34, 64.2%). The mean lesion diameter was 3.7 ± 1.1 cm2 (range 2.0-7.0 cm), the median procedure duration was 70.0 min [interquartile range (IQR) 31.0-113.0 min], and the median treatment speed was 0.086 cm2/min (IQR 0.055-0.152). En-bloc and R0 resection rates were 86.5% (32/37) and 81.1% (30/37), respectively. Procedure speed increased significantly after about 25 cases (P=0.0313). The median hESD procedure treatment speed was 0.159 cm/min (n=16, IQR 0.094-0.193), which was better than with classical ESD (P=0.04). The hESD en-bloc and R0 resection rates were comparable to those of classical ESD (P>0.05). The only complication was bleeding, 5.7% (3/53); no perforation occurred. Recurrence was detected during follow-up (median 30.0 months, IQR 12-48) in one patient (1.7%). ESD is useful and safe for resection of large colorectal polyps, and procedure speed increased considerably after 25 procedures. hESD was faster than ESD, with a high therapeutic resection rate.

8 April 2010 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
BGBarbara Gawrońska-Szklarz
Barbara Gawrońska-Szklarz
ASAndrzej Siuda
Andrzej Siuda
MKMateusz Kurzawski
Mateusz Kurzawski
DBDariusz Bielicki
Dariusz Bielicki
Wojciech M. MarliczWojciech M. Marlicz
Wojciech M. Marlicz
Marek DrozdzikMarek Drozdzik
Marek Drozdzik